SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-15-035503
Filing Date
2015-02-05
Accepted
2015-02-05 16:28:34
Documents
2
Group Members
EXCEL MEDICAL VENTURES, LLCFREDERICK R. BLUMEJUAN ENRIQUEZSTEVEN R. GULLANS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 d868529dsc13ga.htm SC 13G/A 99207
2 EX-99.1 d868529dex991.htm EX-99.1 4921
  Complete submission text file 0001193125-15-035503.txt   105768
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87366 | Film No.: 15580609
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 BOYLSTONE STREET SUITE 1585 BOSTON MA 02199
Business Address 800 BOYLSTONE STREET SUITE 1585 BOSTON MA 02199 617-450-9800
EXCEL MEDICAL FUND LP (Filed by) CIK: 0001428044 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A